• Policy
• MOHW imposes 'CSO Reporting & Training' duty to copromoters
• by Lee, Jeong-Hwan Jul 19, 2024 05:47am

• Company
• Forxiga generics, Jardiance·Envlo, surpass original drug
• by Kim, Jin-Gu Jul 18, 2024 05:49am

• Company
• GSK challenges Meningococcal serogroup B mkt with Bexsero
• by Hwang, Byung-woo Jul 18, 2024 05:49am

• InterView
• ‘We need to actively use acetaminophen ER tablets'
• by Eo, Yun-Ho Jul 18, 2024 05:49am

• Policy
• MSD begins cervical cancer trials for its drug candidate
• by Lee, Hye-Kyung Jul 18, 2024 05:48am

• Company
• Organon introduces JADA system for postpartum hemorrhage
• by Hwang, Byung-woo Jul 18, 2024 05:48am

• Company
• ProGen expands bi-specific antibody R&D with Korean partners
• by Son, Hyung-Min Jul 17, 2024 05:50am

• Opinion
• [Reporter’s view] public-private consultative body
• by Lee, Jeong-Hwan Jul 17, 2024 05:50am

• Company
• Botulinum toxin exports in 1H rise 17%
• by Kim, Jin-Gu Jul 17, 2024 05:50am

• Opinion
• [Reporter's View] Aspirations for Indication-based pricing
• by Eo, Yun-Ho Jul 17, 2024 05:50am